Literature DB >> 16215724

Renal amyloidosis due to pulmonary tuberculosis in a patient with Down syndrome.

Ozan Ozkaya1, M Sükrü Paksu, Kenan Bek, Levent Yildiz, Tunç Fişgin, Nevzat Gürmen, Filiz Karagöz.   

Abstract

A pulmonary-tuberculosis-related renal amyloidosis patient with Down syndrome, who presented with nephrotic syndrome, was studied.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16215724     DOI： 10.1007/s00431-005-0003-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  6 in total

Review 1.  Amyloid precursors and amyloidosis in rheumatoid arthritis.

Authors:  G Cunnane; A S Whitehead
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  1999-12       Impact factor: 4.098

2.  MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study.

Authors:  Banu Balci; Keriman Tinaztepe; Engin Yilmaz; Safak Guçer; Seza Ozen; Rezan Topaloğlu; Nesrin Beşbaş; Meral Ozguç; Ayşin Bakkaloğlu
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

3.  Report on 59 patients with renal amyloidosis.

Authors:  S Paydas
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

4.  Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.

Authors:  Mehmet Tunca; Servet Akar; Fatos Onen; Huri Ozdogan; Ozgur Kasapcopur; Fatos Yalcinkaya; Ercan Tutar; Seza Ozen; Rezan Topaloglu; Engin Yilmaz; Mustafa Arici; Aysin Bakkaloglu; Nesrin Besbas; Tekin Akpolat; Ayhan Dinc; Eren Erken
Journal:  Medicine (Baltimore)       Date:  2005-01       Impact factor: 1.889

5.  Clinical and biochemical outcome of renal amyloidosis.

Authors:  A R Odabas; R Cetinkaya; Y Selcuk; Z Erman; H Bilen
Journal:  Int J Clin Pract       Date:  2002-06       Impact factor: 2.503

Review 6.  Familial mediterranean fever: revisiting an ancient disease.

Authors:  Seza Ozen
Journal:  Eur J Pediatr       Date:  2003-05-16       Impact factor: 3.183
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.